153 related articles for article (PubMed ID: 35040147)
1. Clinical course and outcome of an outpatient clinic population with myasthenia gravis and COVID-19.
Gungor Tuncer O; Deymeer F
Muscle Nerve; 2022 Apr; 65(4):447-452. PubMed ID: 35040147
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 pandemic year in a sample of Polish myasthenia gravis patients: an observational study.
Rzepiński Ł; Zawadka-Kunikowska M
Neurol Neurochir Pol; 2022; 56(1):61-67. PubMed ID: 34346049
[TBL] [Abstract][Full Text] [Related]
3. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
4. Case series of COVID-19 in patients with myasthenia gravis: a single institution experience.
Županić S; Perić Šitum M; Majdak M; Karakaš M; Bašić S; Sporiš D
Acta Neurol Belg; 2021 Aug; 121(4):1039-1044. PubMed ID: 33797054
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 infection in myasthenia gravis: Clinical course and outcomes.
Thomas EV; Bou G; Barton S; Hutto S; Garcia-Santibanez R
Muscle Nerve; 2023 Aug; 68(2):171-175. PubMed ID: 37326164
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 in patients with myasthenia gravis: Epidemiology and disease course.
Businaro P; Vaghi G; Marchioni E; Diamanti L; Arceri S; Bini P; Colombo E; Cosentino G; Alfonsi E; Costa A; Ravaglia S; Mallucci G; Ballante E; Franciotta D; Gastaldi M
Muscle Nerve; 2021 Aug; 64(2):206-211. PubMed ID: 34031902
[TBL] [Abstract][Full Text] [Related]
7. The impact of SARS-CoV-2 immunization on COVID-19 disease course in people with myasthenia gravis.
Bakirtzis C; Boziki MK; Karakasi MV; Moysiadis T; Grigoriadis N
Muscle Nerve; 2023 May; 67(5):412-416. PubMed ID: 36814101
[TBL] [Abstract][Full Text] [Related]
8. Risk and course of COVID-19 in immunosuppressed patients with myasthenia gravis.
Stascheit F; Grittner U; Hoffmann S; Mergenthaler P; Schroeter M; Ruck T; Pawlitzki M; Blaes F; Kaiser J; Schara U; Della-Marina A; Thieme A; Hagenacker T; Jacobi C; Berger B; Urban PP; Knop KC; Schalke B; Lee DH; Kalischewski P; Wiendl H; Meisel A
J Neurol; 2023 Jan; 270(1):1-12. PubMed ID: 36166068
[TBL] [Abstract][Full Text] [Related]
9. Predictive factors for a severe course of COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival.
Jakubíková M; Týblová M; Tesař A; Horáková M; Vlažná D; Ryšánková I; Nováková I; Dolečková K; Dušek P; Piťha J; Voháňka S; Bednařík J
Eur J Neurol; 2021 Oct; 28(10):3418-3425. PubMed ID: 34080271
[TBL] [Abstract][Full Text] [Related]
10. Clinical features and outcomes of patients with myasthenia gravis affected by COVID-19: A single-center study.
Karimi N; Fatehi F; Okhovat AA; Abdi S; Sinaei F; Sikaroodi H; Vahabi Z; Nafissi S
Clin Neurol Neurosurg; 2022 Nov; 222():107441. PubMed ID: 36174408
[TBL] [Abstract][Full Text] [Related]
11. Myasthenia gravis and COVID-19: A case series and comparison with literature.
Saied Z; Rachdi A; Thamlaoui S; Nabli F; Jeridi C; Baffoun N; Kaddour C; Belal S; Ben Sassi S
Acta Neurol Scand; 2021 Sep; 144(3):334-340. PubMed ID: 33914898
[TBL] [Abstract][Full Text] [Related]
12. Clinical course and outcome of Covid-19 in patients with myasthenia gravis.
Aktoz G; Boz C; Zengin S; Okumus AC; Horozoglu H; Kara F; Oral E; Ozmenoglu M
Neurol Res; 2023 Jun; 45(6):583-589. PubMed ID: 36681934
[TBL] [Abstract][Full Text] [Related]
13. Myasthenia gravis and telemedicine: a lesson from COVID-19 pandemic.
Ricciardi D; Casagrande S; Iodice F; Orlando B; Trojsi F; Cirillo G; Clerico M; Bozzali M; Leocani L; Abbadessa G; Miele G; Tedeschi G; Bonavita S; Lavorgna L;
Neurol Sci; 2021 Dec; 42(12):4889-4892. PubMed ID: 34436726
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome.
Ramaswamy SB; Govindarajan R
J Neuromuscul Dis; 2020; 7(3):361-364. PubMed ID: 32508329
[TBL] [Abstract][Full Text] [Related]
15. Myasthenia gravis exacerbation and myasthenic crisis associated with COVID-19: case series and literature review.
Rodrigues CL; de Freitas HC; Lima PRO; de Oliveira Junior PH; Fernandes JMA; D'Almeida JAC; Nóbrega PR
Neurol Sci; 2022 Apr; 43(4):2271-2276. PubMed ID: 35039987
[TBL] [Abstract][Full Text] [Related]
16. Impact of Coronavirus Disease 2019 in a French Cohort of Myasthenia Gravis.
Solé G; Mathis S; Friedman D; Salort-Campana E; Tard C; Bouhour F; Magot A; Annane D; Clair B; Le Masson G; Soulages A; Duval F; Carla L; Violleau MH; Saulnier T; Segovia-Kueny S; Kern L; Antoine JC; Beaudonnet G; Audic F; Kremer L; Chanson JB; Nadaj-Pakleza A; Stojkovic T; Cintas P; Spinazzi M; Foubert-Samier A; Attarian S
Neurology; 2021 Apr; 96(16):e2109-e2120. PubMed ID: 33568541
[TBL] [Abstract][Full Text] [Related]
17. Comment on "Predictive factors for a severe course of COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic status and survival" by Jakubíková et al.
Galassi G; Marchioni A
Eur J Neurol; 2022 Jan; 29(1):e5-e6. PubMed ID: 34586695
[No Abstract] [Full Text] [Related]
18. Electronic health record derived-impact of COVID-19 on myasthenia gravis.
Roy B; Kovvuru S; Nalleballe K; Onteddu SR; Nowak RJ
J Neurol Sci; 2021 Apr; 423():117362. PubMed ID: 33639420
[No Abstract] [Full Text] [Related]
19. TREATMENT OF MYASTHENIA GRAVIS PATIENTS WITH COVID-19: REVIEW OF THE LITERATURE.
Županić S; Lazibat I; Rubinić Majdak M; Jeličić M
Acta Clin Croat; 2022 Feb; 60(3):496-509. PubMed ID: 35282492
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 in patients with myasthenia gravis: a single-center retrospective study in China.
Li J; Zheng Y; Zhao Y; Qi K; Lin G; Liu R; Hao H; Wang Z; Yuan Y; Gao F
Neurol Sci; 2024 Jul; 45(7):2969-2976. PubMed ID: 38652194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
